Published in Eur J Appl Physiol Occup Physiol on January 01, 1992
Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A (1977) 2.79
Behavioral and neuroendocrine characteristics of the night-eating syndrome. JAMA (1999) 2.71
Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost (1983) 1.96
Blood borne tissue factor revisited. Thromb Res (2007) 1.65
Synthesis of intrinsic factor X activator. Inhibition of the function of formed activator by antibodies to factor VIII and to factor IX. Biochemistry (1970) 1.62
Induction of tissue factor expression in whole blood: lack of evidence for the presence of tissue factor expression in granulocytes. Thromb Haemost (2000) 1.58
The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin. Scand J Haematol (1982) 1.51
Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator. Blood (1977) 1.50
Prostate cancer abdominal metastases detected with indium-111 capromab pendetide. J Nucl Med (1998) 1.49
Human leukocyte elastase and cathepsin G inactivate factor VII by limited proteolysis. Thromb Haemost (1993) 1.45
Resistance to activated protein C is reduced in women using oral contraceptives. Blood Coagul Fibrinolysis (1994) 1.45
Hemophilia B: characterization of genetic variants and detection of carriers. Blood (1977) 1.20
The inflammatory properties of contained and noncontained lumbar disc herniation. Spine (Phila Pa 1976) (1997) 1.19
Formation of intrinsic factor-X activator activity, with special reference to the role of thrombin. Br J Haematol (1971) 1.16
The effect of short-term cold exposure on risk factors for cardiovascular disease. Thromb Res (1999) 1.15
Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange. Br Med J (Clin Res Ed) (1984) 1.14
Quantitation of endotoxin in blood from patients with meningococcal disease using a limulus lysate test in combination with chromogenic substrate. Infection (1983) 1.13
Purification and some characteristics of the coagulation factor IX from human plasma. Biochem J (1975) 1.12
Macrophages produce blood coagulation factors. FEBS Lett (1980) 1.07
Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion. Blood (1979) 1.07
Granulocytes enhance LPS-induced tissue factor activity in monocytes via an interaction with platelets. J Leukoc Biol (1993) 1.06
Electroimmunoassay of factor IX in hemophilia B. Thromb Res (1975) 1.05
Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII. J Clin Invest (1979) 1.04
Activation of the coagulation factor VII by tissue thromboplastin and calcium. Biochemistry (1972) 1.03
Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro. Thromb Haemost (2000) 1.01
Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI. J Biol Chem (1978) 0.99
The effect of antithrombin III on the activity of the coagulation factors VII, IX and X. Thromb Haemost (1976) 0.98
Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets. Br J Haematol (1984) 0.97
Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer. Urology (1999) 0.97
Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates. Circulation (1993) 0.96
Usefulness of aspirin plus dipyridamole in reducing left ventricular thrombus formation in anterior wall acute myocardial infarction. Am J Cardiol (1989) 0.95
Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer. Am J Surg (1999) 0.94
Production of blood coagulation factor V and tissue thromboplastin by macrophages in vitro. FEBS Lett (1981) 0.93
Gel filtration properties of factors II, VII, IX, IX a , and X. Thromb Diath Haemorrh (1972) 0.93
A novel biological effect of platelet factor 4 (PF4): enhancement of LPS-induced tissue factor activity in monocytes. J Leukoc Biol (1995) 0.93
Biphasic changes in leukocytes induced by strenuous exercise. Eur J Appl Physiol Occup Physiol (1991) 0.92
Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium-111 capromab pendetide. Cancer (1998) 0.90
The localization of a vitamin K-induced modification in an N-terminal fragment of human prothrombin. Biochem J (1974) 0.90
Activation of purified plasma factor VII by human plasmin, plasma kallikrein, and activated components of the human intrinsic blood coagulation system. Thromb Res (1974) 0.89
The mandatory role of complement in the endotoxin-induced synthesis of tissue thromboplastin in blood monocytes. FEBS Lett (1982) 0.89
Studies, with a luminogenic peptide substrate, on blood coagulation factor X/Xa produced by mouse peritoneal macrophages. Biochem J (1982) 0.89
Radioimmunodetection of implanted tumors with gamma probe. NCI Monogr (1987) 0.89
Does ovarian stimulation for in-vitro fertilization induce a hypercoagulable state? Hum Reprod (1991) 0.87
Activation of 125I-factor IX and 125I-factor X: effect of tissue factor and factor VII, factor Xa and thrombin. Scand J Haematol (1980) 0.87
Modulation of blood cell activation by four commonly used anticoagulants. Thromb Haemost (1997) 0.86
Comparative effects of prolonged intake of highly purified fish oils as ethyl ester or triglyceride on lipids, haemostasis and platelet function in normolipaemic men. Eur J Clin Nutr (1993) 0.85
Evidence for the participation of both activated factor XII and activated factor IX in cold-promoted activation of factor VII. Thromb Res (1978) 0.85
C3 is activated in hereditary angioedema, and C1/C1-inhibitor complexes rise during physical stress in untreated patients. Scand J Immunol (1995) 0.85
Effects of dietary marine oils and olive oil on fatty acid composition, platelet membrane fluidity, platelet responses, and serum lipids in healthy humans. Lipids (1998) 0.85
Inhibition of the thrombin-fibrinogen reaction by a macromolecular factor from rat liver. Biochem J (1972) 0.85
Increased plasma levels of endotoxin and corresponding changes in circulatory performance in a porcine sepsis model: the effect of antibiotic administration. Prog Clin Biol Res (1988) 0.84
Mononuclear phagocyte thromboplastin, bacterial counts and endotoxin levels in experimental endogenous gram-negative sepsis. Acta Chir Scand (1986) 0.84
The production of tumour necrosis factor, tissue thromboplastin, lactoferrin and cathepsin C during lipopolysaccharide stimulation in whole blood. Scand J Clin Lab Invest (1990) 0.84
Enhanced endothelium-dependent vasodilatation in human skin vasculature induced by physical conditioning. Eur J Appl Physiol Occup Physiol (1998) 0.83
Mononuclear phagocyte thromboplastin and endotoxin in patients with secondary bacterial peritonitis. Scand J Gastroenterol (1987) 0.83
Effect of marine oils supplementation on coagulation and cellular activation in whole blood. Lipids (1995) 0.82
Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor. Thromb Haemost (1981) 0.82
The development of monospecific antibodies against human thromboplastin apoprotein (apoprotein III) and their application in the immunocytochemical detection of the antigen in blood cells. Thromb Res (1987) 0.82
Indium-111-pentetreotide scanning versus conventional imaging techniques for the localization of gastrinoma. Surgery (1995) 0.81
Activation pathways of the coagulation system in normal haemostasis. Scand J Haematol (1984) 0.81
The role of arachidonic acid release and lipoxygenase pathway in lipopolysaccharide-induced thromboplastin activity in monocytes. Blood Coagul Fibrinolysis (1991) 0.81
Increased lipopolysaccharide-induced tissue factor activity and tumour necrosis factor production in monocytes after intake of aspirin: possible role of prostaglandin E2. Blood Coagul Fibrinolysis (1992) 0.81
Experimental gram-negative septicemia: thromboplastin generation in mononuclear phagocytes from different anatomical sites. Thromb Res (1987) 0.81
Influence of a concentrated ethylester compound of n-3 fatty acids on lipids, platelets and coagulation in patients undergoing coronary bypass surgery. Thromb Haemost (1991) 0.80
Factor IX variants of hemophilia B. The effect of activated factor XI and the reaction product of factor VII and tissue factor on the abnormal factor IX molecules. Thromb Res (1979) 0.80
Evidence for exclusive role of the p55 tumor necrosis factor (TNF) receptor in mediating the TNF-induced collagenase expression by human dermal fibroblasts. J Invest Dermatol (1996) 0.80
Formation and persistence of procoagulant and fibrinolytic activities in circulation after strenuous physical exercise. Thromb Haemost (1990) 0.80
On commonness and rarity of thyroid hormone resistance: a discussion based on mechanisms of reduced sensitivity in peripheral tissues. Med Hypotheses (2007) 0.79
Coupled amidolytic assay for factor VII: its use with a clotting assay to determine the activity state of factor VII. Blood (1978) 0.79
Factor VIIa in patients with C1-inhibitor deficiency. Thromb Haemost (1995) 0.79
Blood coagulation in patients with benign and malignant tumours before and after surgery. Special reference to thromboplastin generation in monocytes. Scand J Haematol (1984) 0.79
A long-term seal- and cod-liver-oil supplementation in hypercholesterolemic subjects. Lipids (2001) 0.79
Lack of ability to synthesize tissue factor by endothelial cells in intact human saphenous veins. Blood Coagul Fibrinolysis (1990) 0.79
Effect of strenuous exercise on blood monocytes and their relation to coagulation. Med Sci Sports Exerc (1989) 0.79
Thromboplastin activity of blood monocytes after total hip replacement. Scand J Clin Lab Invest (1990) 0.79
Immunological studies on the blood coagulation Factor X and its warfarin-induced precursor. Thromb Diath Haemorrh (1974) 0.78
Cellular activation responses in blood in relation to lipid pattern: healthy men and women in families with myocardial infarction or cancer. Blood Coagul Fibrinolysis (2002) 0.78
Tissue thromboplastin generation in circulating mononuclear phagocytes and development of coagulation disorders during E. coli endotoxinaemia in pigs. Acta Chir Scand (1985) 0.78
Iodine-131 labeled anti-CEA antibodies uptake by Hürthle cell carcinoma. Clin Nucl Med (1985) 0.78
Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood--a beneficial effect on atherogenesis and thrombus formation? Am J Obstet Gynecol (1995) 0.78
The effect of melatonin on cellular activation processes in human blood. J Pineal Res (1999) 0.78
Increased sensitivity to thromboplastin synthesis in blood monocytes from pre-eclamptic patients. Br J Obstet Gynaecol (1985) 0.78
Opposite circadian rhythms in melatonin and tissue factor pathway inhibitor type 1: does daylight affect coagulation? J Thromb Haemost (2006) 0.78
The interaction of the protein and phospholipid components of tissue thromboplastin (factor III) with the factors VII and X. Scand J Haematol (1975) 0.78
Processing of marine foods. Meat Sci (1996) 0.78
Experimental gram-negative peritonitis: decreased thromboplastin activity in organs with a simultaneous rise of thromboplastin in blood monocytes and peritoneal macrophages. Res Exp Med (Berl) (1986) 0.78
Evidence against collagen activation of platelet-associated factor XI as a mechanism for initiating intrinsic clotting. Scand J Haematol (1979) 0.78
Design and optimization of a breast coil for magnetic resonance imaging. Magn Reson Imaging (1993) 0.78
Effect of antibiotics on gram-negative sepsis in the rat. Lack of endotoxin burst. Acta Chir Scand (1987) 0.77
The effect of factor IX and factor X on blood platelets. Scand J Haematol (1974) 0.77
A new protective solution for hypothermic storage of free vein grafts in cardiovascular surgery. Scand J Clin Lab Invest (1992) 0.77
How to measure factor VII and factor VII activation. Haemostasis (1983) 0.77
Tissue factor expression in monocytes: in vitro compared to ex vivo. Thromb Haemost (2000) 0.77
Heparin for infants and children with meningococcal septicemia. Results of a randomized therapeutic trial. NIPH Ann (1983) 0.77